177 related articles for article (PubMed ID: 15068834)
1. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
Krishnan K; Aoki T; Ruffin MT; Normolle DP; Boland CR; Brenner DE
Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
[TBL] [Abstract][Full Text] [Related]
2. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
3. Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells.
Boland CR; Chen YF; Rinderle SJ; Resau JH; Luk GD; Lynch HT; Goldstein IJ
Cancer Res; 1991 Jan; 51(2):657-65. PubMed ID: 1985783
[TBL] [Abstract][Full Text] [Related]
4. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
[TBL] [Abstract][Full Text] [Related]
5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
Kilias D; Macrae FA; Sharpe K; Young GP
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
[TBL] [Abstract][Full Text] [Related]
6. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
Murray SC; Sandler RS; Keku TO; Lyles CM; Millikan RC; Bangdiwala SI; Kupper LL; Jiang W; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):715-20. PubMed ID: 8672987
[TBL] [Abstract][Full Text] [Related]
8. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium selenite on deoxycholic acid-induced hyperproliferation of human colonic mucosa in short-term culture.
Bartram HP; Draenert R; Dusel G; Richter F; Liebscher E; Christl SU; Scheppach W; Kasper H
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1085-9. PubMed ID: 9865426
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agent.
Krishnan K; Ruffin MT; Brenner DE
J Cell Biochem Suppl; 1997; 28-29():148-58. PubMed ID: 9589361
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
12. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
[TBL] [Abstract][Full Text] [Related]
13. Oral cancer cells differ from normal oral epithelial cells in tissue like organization and in response to lycopene treatment: an organotypic cell culture study.
Livny O; Kaplan I; Reifen R; Polak-Charcon S; Madar Z; Schwartz B
Nutr Cancer; 2003; 47(2):195-209. PubMed ID: 15087273
[TBL] [Abstract][Full Text] [Related]
14. Quantification of proliferating cell nuclear antigen in large intestinal crypt by computer-assisted image analysis.
Lin HC; Sotnikov AV; Fosdick L; Bostick RM; Willett WC
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):109-14. PubMed ID: 8850271
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
Masuo T; Okamura S; Zhang Y; Mori M
Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
Yu LG; Milton JD; Fernig DG; Rhodes JM
J Cell Physiol; 2001 Feb; 186(2):282-7. PubMed ID: 11169464
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
Lyles CM; Sandler RS; Keku TO; Kupper LL; Millikan RC; Murray SC; Bangdiwala SI; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1994; 3(7):597-605. PubMed ID: 7827591
[TBL] [Abstract][Full Text] [Related]
18. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
[TBL] [Abstract][Full Text] [Related]
20. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
